相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Serum levels of brain-derived neurotrophic factor correlate with the number of T2 MRI lesions in multiple sclerosis
E. R. Comini-Frota et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2012)
Serum level of interleukin-6 in Chinese patients with multiple sclerosis
Ying-Chun Chen et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Sex-related factors in multiple sclerosis susceptibility and progression
Rhonda R. Voskuhl et al.
NATURE REVIEWS NEUROLOGY (2012)
Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis
Dragana Obradovic et al.
VOJNOSANITETSKI PREGLED (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells
Cheryl M. Sweeney et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis
Z. Mikulkova et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia
Jing-Shan Wu et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose
Angele Cucci et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility
Seyed Amir Bahreini et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Functional and Pathogenic Differences of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis
Helena S. Domingues et al.
PLOS ONE (2010)
Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
Verena Brucklacher-Waldert et al.
BRAIN (2009)
Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and Autoimmunity
Caroline E. Sutton et al.
IMMUNITY (2009)
IFN-β Inhibits Human Th17 Cell Differentiation
Vinod S. Ramgolam et al.
JOURNAL OF IMMUNOLOGY (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
Cytokine changes during interferon-beta therapy in multiple sclerosis: Correlations with interferon dose and MRI response
Jerome J. Graber et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
TNF-α, TNF-β and IL-4 gene polymorphisms in Iranian patients with multiple sclerosis
E. Kamali-Sarvestani et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases
Suhayl Dhib-Jalbut et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Expanding the effector CD4 T-cell repertoire: the Th17 lineage
Laurie E. Harrington et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Cytokines and intrathecal IgG synthesis in multiple sclerosis patients during clinical remission
CO Brandao et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2005)
Cytokines in multiple sclerosis: from bench to bedside
J Imitola et al.
PHARMACOLOGY & THERAPEUTICS (2005)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
IL-1-regulated responses in astrocytes: Relevance to injury and recovery
GR John et al.
GLIA (2005)
Development of biomarkers in multiple sclerosis
B Bielekova et al.
BRAIN (2004)
Genetic variants in the tumor necrosis factor receptor II gene in patients with multiple sclerosis
R Ehling et al.
TISSUE ANTIGENS (2004)
Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease
G Raivich et al.
BRAIN RESEARCH REVIEWS (2004)
Increase in CCR5 Δ32/Δ32 genotype in multiple sclerosis
K Pulkkinen et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis
WX Huang et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients
LT Nguyen et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Promoter polymorphism of IL-10 and severity of multiple sclerosis
M Luomala et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
C Lock et al.
NATURE MEDICINE (2002)
Serum cytokine levels do not correlate with disease activity and severity assessed by brain MRI in multiple sclerosis
J Kraus et al.
ACTA NEUROLOGICA SCANDINAVICA (2002)
Interferon-β therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production
AA Byrnes et al.
ANNALS OF NEUROLOGY (2002)
Disease modifying therapies in multiple sclerosis - Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines
DS Goodin et al.
NEUROLOGY (2002)
Interleukin-6 expression in human multiple sclerosis lesions
LM Schönrock et al.
NEUROSCIENCE LETTERS (2000)
Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production
CM Pelfrey et al.
JOURNAL OF IMMUNOLOGY (2000)
IFN-β-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism:: Relevance to IFN-β-1b therapeutic effects in multiple sclerosis
X Wang et al.
JOURNAL OF IMMUNOLOGY (2000)
Interferon-γ modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis
S Pouly et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)